Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 10
Submit an article Journal homepage
684
Views
17
CrossRef citations to date
0
Altmetric
Special Focus: New Developments in Cancer Vaccines - Reviews

VLPs and particle strategies for cancer vaccines

Francesca UngaroDepartment of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy
,
Claudia ConteDepartment of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy
,
Fabiana QuagliaDepartment of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, 80131, Napoli, Italy
,
Maria Lina TorneselloDeptartment of Experimental Oncology, Laboratory of Molecular Biology and Viral Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Pascale” - IRCCS, Via Mariano Semmola 142, 80131 Napoli, Italy
,
Franco M BuonaguroDeptartment of Experimental Oncology, Laboratory of Molecular Biology and Viral Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Pascale” - IRCCS, Via Mariano Semmola 142, 80131 Napoli, Italy
&
Luigi BuonaguroDeptartment of Experimental Oncology, Laboratory of Molecular Biology and Viral Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione Pascale” - IRCCS, Via Mariano Semmola 142, 80131 Napoli, ItalyCorrespondence[email protected]
Pages 1173-1193 | Published online: 09 Jan 2014

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luigi Buonaguro, Luigi Aurisicchio, Franco M Buonaguro & Gennaro Ciliberto. (2013) New developments in cancer vaccines. Expert Review of Vaccines 12:10, pages 1109-1110.
Read now
Giorgio Parmiani, Carolina Cimminiello & Cristina Maccalli. (2013) Increasing immunogenicity of cancer vaccines to improve their clinical outcome. Expert Review of Vaccines 12:10, pages 1111-1113.
Read now

Articles from other publishers (15)

Alireza Milani, Elnaz Agi, Mohammad Hassan Pouriayevali, Mahdieh Motamedi-Rad, Fatemeh Motevalli & Azam Bolhassani. (2022) Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes. International Immunopharmacology 113, pages 109406.
Crossref
Robabehbeygom Ghafelehbashi, Melina Farshbafnadi, Niloofar Shokraneh Aghdam, Shahin Amiri, Mitra Salehi & Sepideh Razi. (2022) Nanoimmunoengineering strategies in cancer diagnosis and therapy. Clinical and Translational Oncology 25:1, pages 78-90.
Crossref
Soumya Badrinath, Maxence O. Dellacherie, Aileen Li, Shiwei Zheng, Xixi Zhang, Miguel Sobral, Jason W. Pyrdol, Kathryn L. Smith, Yuheng Lu, Sabrina Haag, Hamza Ijaz, Fawn Connor-Stroud, Tsuneyasu Kaisho, Glenn Dranoff, Guo-Cheng Yuan, David J. Mooney & Kai W. Wucherpfennig. (2022) A vaccine targeting resistant tumours by dual T cell plus NK cell attack. Nature 606:7916, pages 992-998.
Crossref
Anna Lucia Tornesello, Maria Tagliamonte, Franco M. Buonaguro, Maria Lina Tornesello & Luigi Buonaguro. (2022) Virus-like Particles as Preventive and Therapeutic Cancer Vaccines. Vaccines 10:2, pages 227.
Crossref
Tong Ye, Feng Li, Guanghui Ma & Wei Wei. (2021) Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors. Advanced Drug Delivery Reviews 177, pages 113927.
Crossref
Yuhao Hao, Xingyu Zhou, Rui Li, Zechenxi Song & Yuanzeng Min. (2019) Advances of functional nanomaterials for cancer immunotherapeutic applications. WIREs Nanomedicine and Nanobiotechnology 12:2.
Crossref
Shasha You, Xiaoyu Guo, Xiaomei Xue, Yongyong Li, Haiqing Dong, Haiying Ji, Ting Hong, Yazhong Wei, Xueyin Shi & Bin He. (2019) PCSK9 Hapten Multicopy Displayed onto Carrier Protein Nanoparticle: An Antiatherosclerosis Vaccine. ACS Biomaterials Science & Engineering 5:9, pages 4263-4271.
Crossref
Natalie J. Kingston, Liriye Kurtovic, Renae Walsh, Carina Joe, George Lovrecz, Stephen Locarnini, James G. Beeson & Hans J. Netter. (2019) Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein. Vaccine 37:12, pages 1674-1684.
Crossref
Xuanwei Ding, Dong Liu, George Booth, Wei Gao & Yuan Lu. (2018) Virus-Like Particle Engineering: From Rational Design to Versatile Applications. Biotechnology Journal 13:5, pages 1700324.
Crossref
Hui Qiu, Yuanzeng Min, Zach Rodgers, Longzhen Zhang & Andrew Z. Wang. (2017) Nanomedicine approaches to improve cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 9:5.
Crossref
M. Tagliamonte, M.L. Tornesello, F.M. Buonaguro & L. Buonaguro. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development 205 219 .
Huiting Su, Bing Li, Lan Zheng, Haixia Wang & Liping Zhang. (2016) Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma. Oncotarget 7:30, pages 48401-48411.
Crossref
A. Petrizzo, C. Conte, M. Tagliamonte, M. Napolitano, K. Bifulco, V. Carriero, A. De Stradis, M. L. Tornesello, F. M. Buonaguro, F. Quaglia & L. Buonaguro. (2015) Functional characterization of biodegradable nanoparticles as antigen delivery system. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
John H Carra, Karen A O Martins, Rowena D Schokman, Camenzind G Robinson, Jesse T Steffens & Sina Bavari. (2015) A thermostable, chromatographically purified Ebola nano-VLP vaccine. Journal of Translational Medicine 13:1.
Crossref
Dan Yan, Yan-Quan Wei, Hui-Chen Guo & Shi-Qi Sun. (2015) The application of virus-like particles as vaccines and biological vehicles. Applied Microbiology and Biotechnology 99:24, pages 10415-10432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.